A novel mechanism for complement activation at the surface of B cells following antigen binding

Journal of Immunology

Volumn 177, Issue 8, 2006, Pages 5155-5162

  Manderson, Anthony P ^a,b,c   Quah, Ben ^a   Botto, Marina ^b   Goodnow, Chris C ^a   Walport, Mark J ^b,d   Parish, Chris R ^a  

^a Australian National University   (Australia)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN M;

ANIMAL CELL; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 33749510093     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.8.5155     Document Type: Article

References (44)

1. Pepys, M. B. 1972. Role of complement in induction of the allergic response. Nat. New Biol. 237: 157-159.
2. Pepys, M. B. 1974. Role of complement in induction of antibody production in vivo: effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J. Exp. Med. 140: 126-145.
3. Feldmann, M., and M. B. Pepys. 1974. Role of C3 in in vitro lymphocyte cooperation. Nature 249: 159-161.
4. Fischer, M. B., M. Ma, S. Goerg, X. Zhou, J. Xia, O. Finco, S. Han, G. Kelsoe, R. G. Howard, T. L. Rothstein, et al. 1996. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157: 549-556.
5. Cutler, A. J., M. Botto, D. van Essen, R. Rivi, K. A. Davies, D. Gray, and M. J. Walport. 1998. T cell-dependent immune response in C1q-deficient mice: defective interferon γ production by antigen-specific T cells. J. Exp. Med. 187: 1789-1797.
6. Lay, W. H., and V. Nussenzweig. 1968. Receptors for complement of leukocytes, J. Exp. Med. 128: 991-1009.
7. Thyphronitis, G., T. Kinoshita, K. Inoue, J. E. Schweinle, G. C. Tsokos, E. S. Metcalf, F. D. Finkelman, and J. E. Balow. 1991. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J. Immunol. 147: 224-230.
8. Heyman, B., E. J. Wiersma, and T. Kinoshita. 1990. In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody, J. Exp. Med. 172: 665-668.
9. Hebell, T., J. M. Aheam, and D. T. Fearon. 1991. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 254: 102-105.
10. Gustavsson, S., T. Kinoshita, and B. Heyman. 1995. Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction. J. Immunol. 154: 6524-6528.
11. Molina, H., V. M. Holers, B. Li, Y. Fung, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R. W. Karr, and D. D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93: 3357-3361.
12. Ahearn, J. M., M. B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R. G. Howard, T. L. Rothstein, and M. C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4: 251-262.
13. Cherukuri, A., P. C. Cheng, and S. K. Pierce. 2001. The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens. J. Immunol. 167: 163-172.
14. Cherukuri, A., P. C. Cheng, H. W. Sohn, and S. K. Pierce. 2001. The CD19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity 14: 169-179.
15. Fearon, D. T., and R. H. Carter. 1995. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13: 127-149.
16. Fearon, D. T., and M. C. Carroll. 2000. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18: 393-422.
17. Boes, M., A. P. Prodeus, T. Schmidt, M. C. Carroll, and J. Chen. 1998. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J. Exp. Med. 188: 2381-2386.
18. Dennert, G. 1971. The mechanism of antibody-induced stimulation and inhibition of the immune response. J. Immunol. 106: 951-955.
19. Harte, P. G., A. Cooke, and J. H. Playfair. 1983. Specific monoclonal IgM is a potent adjuvant in murine malaria vaccination. Nature 302: 256-258.
20. Heyman, B., G. Andrighetto, and H. Wigzell. 1982. Antigen-dependent IgM-mediated enhancement of the sheep erythrocyte response in mice: evidence for induction of B cells with specificities other than that of the injected antibodies. J. Exp. Med. 155: 994-1009.
21. Pearlman, D. S. 1967. The influence of antibodies on immunologic responses. I. The effect on the response to particulate antigen in the rabbit. J. Exp. Med. 126: 127-148.
22. Heyman, B., L. Pilstrom, and M. J. Shulman. 1988. Complement activation is required for IgM-mediated enhancement of the antibody response. J. Exp. Med. 167: 1999-2004.
23. Boes, M., C. Esau, M. B. Fischer, T. Schmidt, M. Carroll, and J. Chen. 1998. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol. 160: 4776-4787.
24. Ehrenstein, M. R., T. L. O'Keefe, S. L. Davies, and M. S. Neuberger. 1998. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc. Natl. Acad. Sci. USA 95: 10089-10093.
25. Dempsey, P. W., M. E. Allison, S. Akkaraju, C. C. Goodnow, and D. T. Fearon. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271: 348-350.
26. Ross, T. M., Y. Xu, R. A. Bright, and H. L. Robinson. 2000. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat. Immunol. 1: 127-131.
27. Carroll, M. C. 2000. The role of complement in B cell activation and tolerance. Adv. Immunol. 74: 61-88.
28. Botto, M., C. Dell'Agnola, A. E. Bygrave, E. M. Thompson, H. T. Cook, F. Petry, M. Loos, P. P. Pandolfi, and M. J. Walport. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19: 56-59.
29. Brink, R., C. C. Goodnow, J. Crosbie, E. Adams, J. Ens, D. Y. Mason, S. B. Hartley, and A. Basten. 1992. Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen. J. Exp. Med. 176: 991-1005.
30. Goodnow, C. C., J. Crosbie, S. Adelstein, T. B. Lavoie, S. J. Smith-Gill, R. A. Brink, H. Pritchard-Briscoe, J. S. Wotherspoon, R. H. Loblay, K. Raphael, et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334: 676-682.
31. Prager, E. M., and A. C. Wilson. 1971. The dependence of immunological cross-reactivity upon sequence resemblance among lysozymes. I. Micro-complement fixation studies. J. Biol. Chem. 246: 5978-5989.
32. Prager, E. M., and A. C. Wilson. 1971. Multiple lysozymes of duck egg white, J. Biol. Chem. 246: 523-530.
33. Weston, S. A., and C. R. Parish. 1990. New fluorescent dyes for lymphocyte migration studies: analysis by flow cytometry and fluorescence microscopy. J. Immunol. Methods 133: 87-97.
34. Manderson, A. P., M. C. Pickering, M. Botto, M. J. Walport, and C. R. Parish. 2001. Continual low-level activation of the classical complement pathway. J. Exp. Med. 194: 747-756.
35. Cutler, A. J., R. J. Cornall, H. Ferry, A. P. Manderson, M. Botto, and M. J. Walport. 2001. Intact B cell tolerance in the absence of the first component of the classical complement pathway. Eur. J. Immunol. 31: 2087-2093.
36. Lavoie, T. B., W. N. Drohan, and S. J. Smith-Gill. 1992. Experimental analysis by site-directed mutagenesis of somatic mutation effects on affinity and fine specificity in antibodies specific for lysozyme. J. Immunol. 148: 503-513.
37. Rossbacher, J., and M. J. Shlomchik. 2003. The B cell receptor itself can activate complement to provide the complement receptor 1/2 ligand required to enhance B cell immune responses in vivo. J. Exp. Med. 198: 591-602.
38. Fischer, M. B., S. Goerg, L. Shen, A. P. Prodeus, C. C. Goodnow, G. Kelsoe, and M. C. Carroll. 1998. Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science 280: 582-585.
39. Lutz, H. U. 1999. How pre-existing, germline-derived antibodies and complement may help induce a primary immune response to nonself. Scand. J. Immunol. 49: 224-228.
40. Kavai, M., J. M. Rasmussen, G. Baatrup, A. Zsindely, and S. E. Svehag. 1988. Inefficient binding of IgM immune complexes to erythrocyte C3b-C4b receptors (CR1) and weak incorporation of C3b-iC3b into the complexes. Scand. J. Immunol. 28: 123-128.
41. Borsos, T., and H. J. Rapp. 1965. Complement fixation on cell surfaces by 19S and 7S antibodies. Science 150: 505-506.
42. Feinstein, A., N. Richardson, and M. J. Taussig. 1986. Immunoglobulin flexibility in complement activation. Immunol. Today 7: 169.
43. De Fougerolles, A. R., F. Batista, E. Johnsson, and D. T. Fearon. 2001. IgM and stromal cell-associated heparan sulfate/heparin as complement- independent ligands for CD19. Eur. J. Immunol. 31: 2189-2199.
44. Hasegawa, M., M. Fujimoto, J. C. Poe, D. A. Steeber, and T. F. Tedder. 2001. CD19 can regulate B lymphocyte signal transduction independent of complement activation. J. Immunol. 167: 3190-3200.